Abstract: A device comprising at least one controller handset possessing a housing and at least one control element that is arranged so as to protrude from the housing and to be movable with respect to the housing so as to allow a user to control at least one movement of at least one object that is external to the device, and a contactless transponder having at least one antenna that is housed in the at least one control element.

Abstract: A formulation information management method includes: acquiring, by a server from a first terminal, individual information associated with a first individual and infection information indicating an infectious disease with which the first individual has been infected, as results of examining infectious diseases of livestock; acquiring, by the server from a second terminal, the individual information and formulation information indicating a blood product manufactured from blood containing blood collected when dissecting the first individual; generating, by the server, related information that associates the infection information and the formulation information based on the individual information; storing, by the server, the related information in a storage; and acquiring, by the server, infection information of a second individual; and in response to acquiring the infection information of the second individual, outputting, by the server, the formulation information associated by the related information with inf

Abstract: A method for inhibiting renal hypofunction in a non-human animal includes administering cat-derived erythropoietin to the non-human animal. The non-human animal may have renal hypofunction. The non-human animal may have chronic kidney disease and the renal hypofunction may be caused by the chronic kidney disease. The cat-derived erythropoietin may be administered repeatedly at a time interval of 7 to 30 days.

Abstract: There are provided a tool and an auxiliary tool that can perform drilling and countersinking at a time to improve working efficiency while securing not only machining accuracy of the drilling but also machining accuracy of the countersinking, by using a tool including drills usable for both of the drilling and the countersinking. A tool including drills usable for drilling and countersinking, includes: a head configured to guide the drills and to hold a workpiece; a linear motion mechanism configured to relatively move the head relative to the drills with a predetermined stroke along with progress of machining by the drills; and a stopper configured to regulate displacement of the head guiding the drills in the machining by abutting on a reception portion at a terminal end of the stroke.

Abstract: A computer of an information processing apparatus is caused to execute steps, the steps including a first specification step of specifying a first direction of a position of a communication apparatus with respect to a position of the information processing apparatus based on communication between the information processing apparatus and the communication apparatus through a predetermined communication method; a reception step of receiving a predetermined operation for designating a direction from a user; a second specification step of specifying a second direction corresponding to the received predetermined operation; a third specification step of specifying the communication apparatus corresponding to the second direction from among a plurality of the communication apparatuses present in a vicinity of the information processing apparatus based on the first direction and the second direction; and an execution step of executing a process relating to the communication apparatus corresponding to the second direc

Abstract: A device includes a chemical solution flow path in which a chemical solution containing polymers flows; a laser beam irradiator configured to irradiate a laser beam to the chemical solution flow path such that an optical path is intersected with a flow direction of the chemical solution in the chemical solution flow path; a light receiving element provided in the optical path passing through the chemical solution flow path; a detector configured to detect, based on a signal output from the light receiving element, an abnormality in a state of polymers corresponding to a majority of the polymers contained in the chemical solution or configured to detect a ratio between a chemical solution containing the polymers and another chemical solution in the chemical solution flow path.

Abstract: A computer of an information processing apparatus is caused to execute steps, the steps including a first specification step of specifying a first direction of a position of a communication apparatus with respect to a position of the information processing apparatus based on communication between the information processing apparatus and the communication apparatus through a predetermined communication method; a reception step of receiving a predetermined operation for designating a direction from a user; a second specification step of specifying a second direction corresponding to the received predetermined operation; a third specification step of specifying the communication apparatus corresponding to the second direction from among a plurality of the communication apparatuses present in a vicinity of the information processing apparatus based on the first direction and the second direction; and an execution step of executing a process relating to the communication apparatus corresponding to the second direc

Abstract: A device comprising at least one controller handset possessing a housing and at least one control element that is arranged so as to protrude from the housing and to be movable with respect to the housing so as to allow a user to control at least one movement of at least one object that is external to the device, and a contactless transponder having at least one antenna that is housed in the at least one control element.

Abstract: A method for inhibiting renal hypofunction in a non-human animal includes administering cat-derived erythropoietin to the non-human animal. The non-human animal may have renal hypofunction. The non-human animal may have chronic kidney disease and the renal hypofunction may be caused by the chronic kidney disease. The cat-derived erythropoietin may be administered repeatedly at a time interval of 7 to 30 days.

Abstract: A main object of the present invention is to provide a novel coated tablet which contains a drug having a guanidino group and does not suffer an obvious color change even when packed in a one-dose pack together with a drug having a (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (DMDO) group. The present invention provides a coated tablet characterized in that an uncoated tablet containing a drug having a guanidino group has been coated with a polyvinyl alcohol for film coating which comprises polyvinyl alcohol, acrylic acid, and methyl methacrylate.

Abstract: An object of the present invention is to provide a compressed composition that is superior in terms of maintaining the function of a film or in terms of content uniformity even during tableting process. The present invention provides a compressed composition, comprising: coated granules containing a physiologically active compound or pharmacologically acceptable salt thereof, and an excipient, wherein the excipient contains at least one selected from the group consisting of low-substituted hydroxypropylcellulose, lactose and crystalline cellulose, and the total amount thereof is 0.5 parts by weight or more in 1 part by weight of the excipient, and the excipient is physically mixed with or coated onto the coated granules followed by compressing at low pressure.

Abstract: A main object of the present invention is to provide a novel coated tablet which contains a drug having a guanidino group and does not suffer an obvious color change even when packed in a one-dose pack together with a drug having a (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (DMDO) group. The present invention provides a coated tablet characterized in that an uncoated tablet containing a drug having a guanidino group has been coated with a polyvinyl alcohol for film coating which comprises polyvinyl alcohol, acrylic acid, and methyl methacrylate.

Abstract: A main object of the present invention is to provide a novel coated tablet which contains a drug having a guanidino group and does not suffer an obvious color change even when packed in a one-dose pack together with a drug having a (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (DMDO) group. The present invention provides a coated tablet characterized in that an uncoated tablet containing a drug having a guanidino group has been coated with a polyvinyl alcohol for film coating which comprises polyvinyl alcohol, acrylic acid, and methyl methacrylate.

Abstract: A main object of the present invention is to provide a novel coated tablet which contains a drug having a guanidino group and does not suffer an obvious color change even when packed in a one-dose pack together with a drug having a (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (DMDO) group. The present invention provides a coated tablet characterized in that an uncoated tablet containing a drug having a guanidino group has been coated with a polyvinyl alcohol for film coating which comprises polyvinyl alcohol, acrylic acid, and methyl methacrylate.

Abstract: The present invention aims to provide a composition which has an extremely broad range of applications, has an excellent safety, and can be used for preventing, ameliorating, or therapeutically-treating diabetes. The present invention provides an agent for preventing, ameliorating, or therapeutically-treating diabetes or a diabetic complication, a glycemic control agent, and an insulin secretion-promoting agent, each of which contains reduced coenzyme A as an active ingredient. The present invention also provides a method for preventing, ameliorating, or therapeutically-treating diabetes or a diabetic complication, which includes administration of the aforementioned agent.

Abstract: The present invention aims to activate neural cells in brain, and further provide a useful composition having an action to protect intracerebral neural cells from external and internal stresses. An agent for improving a neural cell function containing reduced coenzyme Q as an active ingredient, more specifically, an agent for activating neural cells and an agent for protecting neural cells, is useful, and can be used for the improvement or prophylaxis of central neurological diseases or neuropathy symptoms derived from or associated with a neurodegenerative disease, promotion of cognitive function or improvement of learning and memory disorders.

Abstract: A composition containing a licorice polyphenol and other active ingredient (antioxidant ingredient, polyphenol other than licorice polyphenol or a component relating to lipid absorption or metabolism) is highly safe, can be produced easily, and can be utilized for foods and drinks such as health food, food with health claims (specified health food, food with nutrient function claims) and the like, pharmaceutical products, quasi-drugs, cosmetics and the like. In addition, since the composition has a body fat accumulation suppressing effect, a body fat decomposition promoting effect or energy production promoting effect, it is useful for the treatment of obesity, metabolic syndrome and the like.

Abstract: Provided is a method for suppressing carcinogenesis, treating cancer, or mitigating adverse reactions of anticancer agents, with low prevalence of adverse reactions by administering an effective amount of a reduced coenzyme Q as an active ingredient. In the method, the reduced coenzyme Q can be administered in the form of pharmaceuticals, cosmeceutical, cosmetics, foods such as functional foods (supplements, health aid foods, nutritional supplementary foods, nutrient-fortified foods, nutrient-adjusted foods, health beverages, foods for specified health uses, foods with nutrient function claims), animal drugs, animal feeds, or animal foods.

Abstract: A matrix-addressed type display device has display material sandwiched between two substrates facing each other, and a transparent pixel electrode disposed in matrix arrangement. The display device display characters by the application of a voltage selectively to the transparent pixel electrode by the use of a thin-film transistor. To improve display characteristics, an electric charge capacitor is provided in each pixel. This electric charge capacitor is connected to an adjacent gate electrode path and includes a transparent inner bottom electrode sandwiched between a dielectric substrate and a transparent pixel electrode. A transparent dielectric film is Interposed between the transparent pixel electrode and the transparent inner bottom electrode.

Abstract: An improved method for manufacturing a liquid crystal display unit substantially free from gate electrode breakage but with no increase in the number of manufacturing steps over the conventional method. The liquid crystal display unit includes a TFT array substrate including a plurality of gate electrode lines juxtaposed on a transparent insulating substrate, a plurality of source electrode lines arranged across the gate electrode lines, nonlinear active elements disposed at the intersections of the electrode lines, a confronting electrode substrate having a transparent conductive film on the surface thereof confronting the TFT array substrate, and a liquid crystal display material being held between the confronting electrode substrate and the TFT array substrate. Each of the gate electrode lines is constructed in the form of two layers. One of the two layers is made of display electrode material simultaneously with the formation of the display electrode.